Our quality product service solutions bridge the gaps between technology and patient care by providing custom-tailored cell therapy services, including:
- Contract Manufacturing
- Product & Process Development
- Consulting
- GTP Services
- National Distribution
Robert A. Preti
Corporate Management
Robert A. Preti, Ph.D.
President and Chief Scientific Officer, Member of Board of Managers
rpreti@progenitorcelltherapy.com
Save R. Preti's vCard
Dr. Preti is PCT's President, Chief Scientific Officer, and a member of the Company's Board of Managers. He has held these positions since March 1999.
Previous positions held by Dr. Preti include Scientific Director of HUMC's stem cell laboratory and Scientific Director of the Clinical Services Division at the New York Blood Center (NYBC).
He is one of the country's leading authorities on hematopoietic stem cell engineering and the principal investigator for a number of clinical trials relating to stem cell transplantation. He was a founding member and Treasurer of the International Society for Hematotherapy and Graft Engineering (ISHAGE), now the International Society for Cellular Therapy (ISCT), and is currently both an active member and speaker.
Dr. Preti has authored numerous papers in the field of cell and tissue processing, cell production, and clinical research. He speaks at national and international meetings related to the laboratory aspects of stem cell transplantation. In addition to serving as an inspector for the Foundation for Accreditation of Cellular Therapy (FACT), Dr. Preti also serves on professional, state and federal regulatory committees charged with the development of regulations for cellular therapy.
Dr. Preti received his Doctor of Philosophy degree from New York University, graduating with distinction.
